About this event

  • Date and time Tue 16 May 2023 from 9:00am to 5:00pm
  • Location Royal Society of Medicine
  • Organised by Radiology

Join us to learn about the role and value of next-generation imaging throughout the entire prostate cancer journey, from screening to advanced disease states, using a framework of definable clinical states.

By attending, you will:

  • Understand the pathological states, problems of categorisation, and clinical needs during the entire patient journey
  • Understand how imaging can help meet clinical priorities and so promote the personalisation of care in advancing clinical states
  • Explore how next-generation prostate imaging, such as multiparametric MRI and MRI-directed biopsies, and whole-body MRI and PET/CT assessments with clinical biomarkers, can create opportunities to support and manage pathways of patients


Follow us on: 



Early bird pricing available until 03 April 2023.


RSM Fellow RSM Associate RSM Retired Fellow RSM Trainee RSM Student
£77.00 £46.00 £46.00 £46.00 £24.00

Non - Member

Consultant / GP / SAS Doctors AHP / Nurse / Midwife Trainee Student
£141.00 £84.00 £84.00 £44.00


View the programme

Registration, tea and coffee
Welcome and introduction

Professor Anwar Padhani, Consultant Radiologist, Paul Strickland Scanner Centre

Session 1: Prostate cancer diagnosis

Detection with magnetic resonance imaging including scoring systems

Dr Heminder Kaur Sokhi, Consultant Radiologist, Paul Strickland Scanner Centre

Quality checkpoints in the MRI pathway

Professor Tristan Barrett, Associate Professor, Department of Radiology, University of Cambridge

Panel discussion
Tea and coffee break
Prostate cancer screening – has the time come?

Professor Hashim Ahmed, Consultant Urological Surgeon, Imperial College Healthcare NHS Trust

Artificial intelligence roles in detection

Professor Anwar Padhani

Magnetic resonance imaging directed biopsy strategies

Mr Taimur Shah, Clinical Senior Lecturer and Consultant Urologist, Imperial College London

Panel discussion

Session 2: Prostate cancer staging, treatment and follow up

Chaired by: Professor Anwar Padhani

Advancing disease states – opportunities for imaging

Professor Anwar Padhani

Risk based staging of known cancers and therapy decision making

Professor Giuseppe Petralia, Director, Unit of Precision of imaging and Research, European Institute of Oncology

Treatment selections for known disease

Speaker to be confirmed 

Panel discussion
Tea and coffee break
Biochemical recurrence imaging detection (local and systemic

Dr Tara Barwick, Consultant Radiologist, Imperial College Healthcare NHS Trust 

Advanced prostate cancer – imaging therapy monitoring

Dr Nina Tunariu, Consultant Radiologist, The Royal Marsden NHS Foundation Trust

Panel discussion
Close of day

Finzi presentations

Welcome and introduction
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Awarding of the Finzi prize
End of prize meeting


Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

Registration for this event will close at 1:00am on Monday 15 May 2023. Late registrations will not be accepted.

The agenda is subject to change at any time.

We are only able to share presentations that we have received permission to share. This is at the presenter and the RSM’s discretion. 

All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations. 

This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels. 

Man searching computer

Join the RSM and get free access to digital learning resources

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy free access to a wealth of online  resources, including 5,000 subscription and open access e-journals, 2,000 e-books and 5 key medical databases, to support your clinical decision-making and research.

Become a member